8.84
price down icon1.34%   -0.12
after-market Dopo l'orario di chiusura: 8.93 0.09 +1.02%
loading
Precedente Chiudi:
$8.96
Aprire:
$8.95
Volume 24 ore:
11.70M
Relative Volume:
0.96
Capitalizzazione di mercato:
$11.10B
Reddito:
$15.05B
Utile/perdita netta:
$-883.30M
Rapporto P/E:
-11.95
EPS:
-0.74
Flusso di cassa netto:
$1.89B
1 W Prestazione:
-6.36%
1M Prestazione:
-7.24%
6M Prestazione:
-23.46%
1 anno Prestazione:
-25.27%
Intervallo 1D:
Value
$8.75
$8.955
Intervallo di 1 settimana:
Value
$8.75
$9.37
Portata 52W:
Value
$8.75
$13.55

Viatris Inc Stock (VTRS) Company Profile

Name
Nome
Viatris Inc
Name
Telefono
(724) 514-1465
Name
Indirizzo
1000 MYLAN BOULEVARD, CANONSBURG
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
VTRS's Discussions on Twitter

Confronta VTRS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
8.84 11.10B 15.05B -883.30M 1.89B -0.74
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.02 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.14 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.12 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.49 17.75B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.75 14.03B 612.78M -86.37M -62.91M -0.87

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-19 Ripresa Jefferies Buy
2023-10-23 Downgrade BofA Securities Neutral → Underperform
2023-06-23 Downgrade Barclays Equal Weight → Underweight
2023-04-24 Downgrade Barclays Overweight → Equal Weight
2023-02-17 Downgrade BMO Capital Markets Outperform → Market Perform
2023-01-27 Aggiornamento Jefferies Hold → Buy
2022-11-10 Aggiornamento UBS Sell → Neutral
2022-11-08 Aggiornamento Piper Sandler Underweight → Neutral
2022-10-21 Ripresa Jefferies Hold
2022-06-14 Iniziato UBS Sell
2022-05-10 Downgrade Piper Sandler Neutral → Underweight
2022-03-01 Downgrade BofA Securities Buy → Neutral
2022-03-01 Downgrade Raymond James Outperform → Mkt Perform
2021-06-15 Iniziato Citigroup Neutral
2021-04-07 Ripresa RBC Capital Mkts Outperform
2021-03-08 Downgrade Goldman Buy → Neutral
2021-03-02 Downgrade JP Morgan Overweight → Neutral
2021-02-26 Downgrade Wolfe Research Outperform → Peer Perform
2021-01-05 Iniziato Argus Hold
2020-12-14 Iniziato Bernstein Mkt Perform
Mostra tutto

Viatris Inc Borsa (VTRS) Ultime notizie

pulisher
Mar 27, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are - Bluefield Daily Telegraph

Mar 27, 2025
pulisher
Mar 27, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

The Global Market for Paclitaxel Injections Presents an - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Why Pfizer Is My Largest Healthcare Position - The Motley Fool

Mar 27, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris – VTRS - TradingView

Mar 26, 2025
pulisher
Mar 25, 2025

The Human Factor: Device Stress Tests Run Gamut to Mimic Real-World Use - Viatris

Mar 25, 2025
pulisher
Mar 25, 2025

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Mar 25, 2025
pulisher
Mar 25, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire

Mar 24, 2025
pulisher
Mar 23, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - GlobeNewswire

Mar 23, 2025
pulisher
Mar 22, 2025

Viatris Inc. Being Investigated on Behalf of Viatris Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

VTRS Stock Quote - richtv.io

Mar 21, 2025
pulisher
Mar 21, 2025

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Mar 21, 2025
pulisher
Mar 21, 2025

Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateVTRS - ACCESS Newswire

Mar 20, 2025
pulisher
Mar 18, 2025

VTRS Investigation: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Viatris Inc. Announces Quarterly Dividend, Payable on March 18, 2025 -February 27, 2025 at 06:30 am EST - Marketscreener.com

Mar 18, 2025
pulisher
Mar 17, 2025

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now? - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

Opus, Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug - Bloomberg Law

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc.VTRS - PR Newswire

Mar 17, 2025
pulisher
Mar 16, 2025

Viatris Inc. Under Investor Scrutiny: Levi & Korsinsky Launches Securities Investigation - Apna Kal

Mar 16, 2025
pulisher
Mar 15, 2025

Viatris Stock Plummets Over 15% Amid Earnings Miss and FDA Warning – Investors Encouraged to Take Action - Apna Kal

Mar 15, 2025
pulisher
Mar 14, 2025

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation – VTRS - Bluefield Daily Telegraph

Mar 14, 2025
pulisher
Mar 14, 2025

Viatris Inc (VTRS) Volatility Hits 3.27% – Here Is What You Should Do - Stocks Register

Mar 14, 2025
pulisher
Mar 14, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Viatris Inc. (VTRS) And Encourages Shareholders to Reach Out - Markets Insider

Mar 14, 2025
pulisher
Mar 13, 2025

Investors who Lost Money on Viatris Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationVTRS - ACCESS Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Viatris Inc. (VTRS) and Encourages Shareholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

Viatris Inc. (VTRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris Inc. (VTRS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris’s SWOT analysis: generic drug maker’s stock faces headwinds - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris’s SWOT analysis: generic drug maker’s stock faces headwinds By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Viatris Inc. (VTRS) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Viatris at Barclays Conference: Strategic Moves Amid Challenges - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Securities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Mar 11, 2025
pulisher
Mar 11, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Viatris Inc. (VTRS) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 10, 2025

ATTENTION Viatris Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 10, 2025

Viatris Inc. (VTRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 10, 2025
pulisher
Mar 09, 2025

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025 - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Viatris Inc. (VTRS) And Encourages Investors to Connect - Markets Insider

Mar 09, 2025

Viatris Inc Azioni (VTRS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$114.00
price down icon 0.39%
$131.75
price up icon 0.05%
$97.04
price down icon 1.41%
$33.53
price down icon 0.47%
$10.81
price up icon 2.46%
Capitalizzazione:     |  Volume (24 ore):